Meghmani Organics Ltd

Meghmani Organi. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Meghmani Organics Ltd

₹ 99.0 1.57%
30 Jun - close price
meghmani.com BSE: 543331 NSE: MOL
About

Founded in 1986 as M/s Gujarat Industries, the company was incorporated in 1995 as Meghmani Organics Limited. The company manufactures Pigments and Agrochemicals through its 6 manufacturing facilities located in Gujarat. The company is amongst the top 3 Phthalocyanine based pigment players in the world and amongst the top 10 producers of pesticides in India.[1]Meghmani Organics Ltd (MOL) manufactures green and blue pigment products, which are used to manufacture printing ink, plastic, paints, textiles, leather, and rubber.

It also manufactures a wide variety of commonly used pesticides for crop and non-crop applications, this include insect control in wood preservation and food grain storage.

Key Points

Business Segments
A) Agro Chemicals (70% in FY25 vs 76% in FY23): [1] [2] [3] The company manufactures products across the entire value chain, including technicals, intermediates, and formulations for insecticides and herbicides. Key intermediates include cypermethrin acid chloride, meta phenoxy benzaldehyde, and meta phenoxy benzyl alcohol. It has manufacturing facilities at Ankleshwar, Panoli, & Dahej in Gujarat. It generates over 80% revenue from export markets, including Africa, Brazil, Latin America, the US, and Europe. About 45% of the demand comes from the US and Brazil. It has a product registration base of 788 as of FY25 vs 693 in FY23.[4] [5] The company reported revenue and EBITDA growth of 34% and 301% YoY, respectively, in FY25, driven by higher production and improved realization. [6]

Website BSE NSE
  • Market Cap ₹ 2,517 Cr.
  • Current Price ₹ 99.0
  • High / Low ₹ 116 / 56.1
  • Stock P/E
  • Book Value ₹ 59.6
  • Dividend Yield 0.00 %
  • ROCE 3.39 %
  • ROE -0.80 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is expected to give good quarter

Cons

  • Company has low interest coverage ratio.
  • Company has a low return on equity of 2.22% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals

Part of BSE SmallCap BSE Allcap BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
812 783 646 549 574 426 379 352 410 414 544 569 553
678 652 567 497 496 448 371 360 408 408 513 528 488
Operating Profit 134 132 78 53 78 -22 8 -8 2 6 31 41 65
OPM % 16% 17% 12% 10% 14% -5% 2% -2% 0% 1% 6% 7% 12%
27 38 26 24 27 7 12 10 9 9 12 9 14
Interest 7 9 -3 43 16 4 13 27 2 11 26 13 19
Depreciation 17 18 18 18 23 24 23 23 23 23 25 30 29
Profit before tax 136 142 89 15 67 -43 -16 -48 -14 -19 -9 7 31
Tax % 25% 23% 25% 46% 19% -20% -3% -20% 25% -13% 1% 159% 35%
102 109 66 8 54 -34 -15 -38 -18 -17 -9 -4 20
EPS in Rs 4.02 4.29 2.60 0.33 2.13 -1.36 -0.60 -1.50 -0.71 -0.66 -0.36 -0.17 0.78
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 6m Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
700 1,637 2,498 2,553 1,566 2,080
595 1,353 2,119 2,211 1,586 1,936
Operating Profit 105 283 379 342 -19 144
OPM % 15% 17% 15% 13% -1% 7%
130 30 102 114 37 42
Interest 18 11 9 66 46 69
Depreciation 22 51 63 77 92 108
Profit before tax 194 252 409 313 -121 9
Tax % 23% 26% 26% 24% -12% 212%
150 186 304 238 -106 -11
EPS in Rs 29,914.00 37,296.00 11.97 9.35 -4.17 -0.42
Dividend Payout % 17% 19% 12% 15% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 24%
3 Years: -6%
TTM: 33%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 89%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -7%
1 Year: 19%
Return on Equity
10 Years: %
5 Years: 8%
3 Years: 2%
Last Year: -1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 25 25 25 25 25 25
Reserves 961 1,148 1,441 1,644 1,502 1,490
264 268 499 824 837 829
407 533 832 705 674 741
Total Liabilities 1,657 1,974 2,798 3,198 3,039 3,085
481 634 911 1,166 1,152 1,575
CWIP 101 112 188 356 521 83
Investments 191 304 211 183 114 3
885 924 1,487 1,494 1,251 1,425
Total Assets 1,657 1,974 2,798 3,198 3,039 3,085

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
22 333 65 204 250 66
13 -307 -133 -418 -178 31
-26 -14 58 234 -85 -91
Net Cash Flow 8 12 -10 21 -14 6

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 241 92 79 75 101 99
Inventory Days 271 152 161 158 185 173
Days Payable 209 137 144 108 176 159
Cash Conversion Cycle 302 106 96 124 110 113
Working Capital Days 239 89 99 113 132 116
ROCE % 19% 24% 16% -3% 3%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
49.29% 49.37% 49.37% 49.48% 49.50% 49.32% 49.32% 49.32% 49.32% 49.33% 49.33% 49.41%
1.44% 1.64% 1.57% 1.53% 1.50% 1.34% 1.30% 1.52% 1.39% 2.22% 1.90% 1.81%
0.00% 0.08% 0.34% 0.45% 0.45% 0.61% 0.26% 0.20% 0.20% 0.42% 0.27% 0.48%
0.05% 0.05% 0.05% 0.05% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
49.23% 48.87% 48.69% 48.50% 48.51% 48.69% 49.09% 48.93% 49.05% 47.98% 48.46% 48.24%
No. of Shareholders 1,29,4061,30,9921,28,5071,27,1981,31,3361,40,6721,40,8291,52,7031,46,0101,28,8751,27,3921,26,617

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls